Anne Wojcicki Net Worth in 2024
Anne Wojcicki net worth is estimated at around 800 million dollars in 2024, based on public filings, Forbes estimates, and market valuations tied to her stake in 23andMe and other assets. Her wealth has shifted sharply in recent years as 23andMe stock declined from its highs and the company faced restructuring, bankruptcy risk, and a drop in valuation. The figure reflects her position as a co-founder and former CEO of a high-profile biotech firm, not passive income from unrelated ventures.
The estimate comes from a combination of reported holdings in 23andMe, secondary market data on private shares, and public disclosures about her share sales and equity compensation. Because 23andMe stock has been volatile and the company has undergone a reverse stock split, bankruptcy filing, and delisting from Nasdaq, the net worth number can move quickly with market sentiment and restructuring outcomes.
Career Timeline and Key Companies
Anne Wojcicki co-founded 23andMe in 2006 with the goal of democratizing access to genetic data and building a direct-to-consumer DNA testing business. She served as CEO for many years and led the company through its IPO in 2021, a period of rapid growth in consumer genetics, partnerships with pharmaceutical companies, and scrutiny from regulators over health claims and data privacy.
Before 23andMe, she worked as a research analyst in healthcare and biotechnology investing, which shaped her focus on genomics and personalized medicine. Her career path includes roles linked to biotech finance and scientific research, and she is the sister of Susan Wojcicki, former CEO of YouTube, and Janet Wojcicki, an academic in pediatrics and anthropology.
23andMe, Financial Challenges, and Shareholder Impact
23andMe faced serious financial trouble in 2023 and 2024, including a sharp drop in revenue, layoffs, and a bankruptcy filing under Chapter 11, which led to a restructuring of debt and a steep decline in share value. The company's market capitalization fell far below its IPO level, and Anne Wojcicki's personal net worth dropped in line with the falling valuation of her equity stake.
Public filings and news reports show that Wojcicki sold shares in 23andMe at various points, contributing to liquidity needs and reducing her exposure as the stock declined. Investors tracking 23andMe and Anne Wojcicki watch for updates on restructuring progress, potential acquisitions, and any future public or private financing rounds that could affect the value of her remaining holdings.